Location History:
- Mountain View, CA (US) (1998 - 2016)
- Somerset, NJ (US) (2016)
Company Filing History:
8 out of 1,062 
4 out of 75 
2 out of 53 
Years Active: 1998-2016
Title: The Innovative Journey of Jay Douglas Audett
Introduction: Jay Douglas Audett, an accomplished inventor based in Somerset, NJ, has made significant contributions to the field of transdermal drug delivery systems. With a total of 17 patents to his name, Audett’s innovations are characterized by their practical applications and advanced technology.
Latest Patents: Two of Audett's most recent patents showcase his expertise in drug delivery mechanisms. The first, titled "Multilaminate Backing Construction," introduces a novel backing for transdermal delivery systems. This patent focuses on the labeling method of these systems, where the backing layer features a writable medium suitable for inkless printing. His second recent invention, the "Transdermal Nicotine Salt Delivery System," allows for the effective delivery of high nicotine salt loading to individuals. This system utilizes an acrylate polymeric drug reservoir, providing desirable adhesive characteristics while ensuring effective transdermal therapeutic properties.
Career Highlights: Throughout his career, Jay Douglas Audett has held pivotal roles at renowned companies, including Alza Corporation and Cygnus, Inc. His experience in these organizations bolstered his expertise in drug delivery systems and helped him refine his innovative ideas.
Collaborations: Audett has collaborated with notable individuals such as Robert M. Gale and Allison Luciano. Their joint efforts have likely contributed to the advancements seen in Audett's patents, emphasizing the importance of teamwork in the field of innovation.
Conclusion: Jay Douglas Audett stands out as a prominent figure in the realm of pharmaceutical inventions. His patents reflect a commitment to improving drug delivery methods and address real-world medical challenges. As technology continues to advance, Audett's innovations will undoubtedly pave the way for future developments in transdermal therapies.